Bio-Works Technologies Valuation Multiples

Bio-Works Technologies Overview

About Bio-Works Technologies

Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.

Founded

2006

HQ

Employees

25

Website

bio-works.com

Sectors

Life Sciences ToolsBioTech

Financials (FY)

Revenue: $7M

EBITDA: ($2M)

EV

$32M

Valuation Multiples

Multiples.vc

Start free trial

Bio-Works Technologies Financials

Bio-Works Technologies reported last fiscal year revenue of $7M and negative EBITDA of ($2M).

In the same fiscal year, Bio-Works Technologies generated $5M in gross profit, ($2M) in EBITDA losses, and had net loss of ($2M).

Bio-Works Technologies P&L

In the most recent fiscal year, Bio-Works Technologies reported revenue of $7M and EBITDA of ($2M).

Bio-Works Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX

Bio-Works Technologies Stock Performance

Bio-Works Technologies has current market cap of $36M, and enterprise value of $32M.

Bio-Works Technologies' stock price is $0.36.

Bio-Works Technologies Valuation Multiples

Bio-Works Technologies trades at 4.7x EV/Revenue multiple, and (17.8x) EV/EBITDA.

Bio-Works Technologies Financial Valuation Multiples

As of April 19, 2026, Bio-Works Technologies has market cap of $36M and EV of $32M.

Equity research analysts estimate Bio-Works Technologies' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Bio-Works Technologies has a P/E ratio of (21.7x).

Bio-Works Technologies Margins & Growth Rates

Bio-Works Technologies' revenue in the last fiscal year grew by 145%.

Bio-Works Technologies' revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.3M for the same period.

Bio-Works Technologies Public Comps

See public comps and valuation multiples for other Life Sciences Tools comps.

Bio-Works Technologies M&A Activity

Bio-Works Technologies acquired XXX companies to date.

Last acquisition by Bio-Works Technologies was on XXXXXXXX, XXXXX. Bio-Works Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Bio-Works Technologies Investment Activity

Bio-Works Technologies invested in XXX companies to date.

Bio-Works Technologies made its latest investment on XXXXXXXX, XXXXX. Bio-Works Technologies invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).